234 related articles for article (PubMed ID: 24376550)
1. Intravesical resiniferatoxin for the treatment of storage lower urinary tract symptoms in patients with either interstitial cystitis or detrusor overactivity: a meta-analysis.
Guo C; Yang B; Gu W; Peng B; Xia S; Yang F; Wen D; Geng J; Zhang Y; Zheng J
PLoS One; 2013; 8(12):e82591. PubMed ID: 24376550
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravesical Resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation.
Apostolidis A; Gonzales GE; Fowler CJ
Eur Urol; 2006 Dec; 50(6):1299-305. PubMed ID: 16697519
[TBL] [Abstract][Full Text] [Related]
3. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
[TBL] [Abstract][Full Text] [Related]
4. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial.
Silva C; Silva J; Ribeiro MJ; Avelino A; Cruz F
Eur Urol; 2005 Oct; 48(4):650-5. PubMed ID: 15961217
[TBL] [Abstract][Full Text] [Related]
5. Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial.
Kim JH; Rivas DA; Shenot PJ; Green B; Kennelly M; Erickson JR; O'Leary M; Yoshimura N; Chancellor MB
J Spinal Cord Med; 2003; 26(4):358-63. PubMed ID: 14992337
[TBL] [Abstract][Full Text] [Related]
6. Intravesical Botulinum Toxin A Injections for Bladder Pain Syndrome/Interstitial Cystitis: A Systematic Review and Meta-Analysis of Controlled Studies.
Wang J; Wang Q; Wu Q; Chen Y; Wu P
Med Sci Monit; 2016 Sep; 22():3257-67. PubMed ID: 27624897
[TBL] [Abstract][Full Text] [Related]
7. Multiple intravesical instillations of low-dose resiniferatoxin in the treatment of refractory interstitial cystitis.
Peng CH; Kuo HC
Urol Int; 2007; 78(1):78-81. PubMed ID: 17192738
[TBL] [Abstract][Full Text] [Related]
8. [Intravesical instillation of resiniferatoxin for the patients with interstitial cystitis].
Takahashi S; Yanase M; Inoue R; Ichihara K; Masumori N; Tsukamoto T; Igawa Y; Nishizawa O
Hinyokika Kiyo; 2006 Dec; 52(12):911-3. PubMed ID: 17252971
[TBL] [Abstract][Full Text] [Related]
9. Intravesical resiniferatoxin for patients with neurogenic detrusor overactivity.
Watanabe T; Yokoyama T; Sasaki K; Nozaki K; Ozawa H; Kumon H
Int J Urol; 2004 Apr; 11(4):200-5. PubMed ID: 15028097
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis.
Hung MJ; Tsai CP; Lin YH; Huang WC; Chen GD; Shen PS
Taiwan J Obstet Gynecol; 2019 May; 58(3):417-422. PubMed ID: 31122535
[TBL] [Abstract][Full Text] [Related]
11. Effects of early intravesical administration of resiniferatoxin to spinal cord-injured rats in neurogenic detrusor overactivity.
Oliveira R; Coelho A; Franquinho F; Sousa MM; Cruz F; D Cruz C
Neurourol Urodyn; 2019 Aug; 38(6):1540-1550. PubMed ID: 31180583
[TBL] [Abstract][Full Text] [Related]
12. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial.
Payne CK; Mosbaugh PG; Forrest JB; Evans RJ; Whitmore KE; Antoci JP; Perez-Marrero R; Jacoby K; Diokno AC; O'Reilly KJ; Griebling TL; Vasavada SP; Yu AS; Frumkin LR;
J Urol; 2005 May; 173(5):1590-4. PubMed ID: 15821499
[TBL] [Abstract][Full Text] [Related]
13. Prospective, randomized, double-blind study of safety and tolerability of intravesical resiniferatoxin (RTX) in interstitial cystitis (IC).
Chen TY; Corcos J; Camel M; Ponsot Y; Tu le M
Int Urogynecol J Pelvic Floor Dysfunct; 2005; 16(4):293-7. PubMed ID: 15818465
[TBL] [Abstract][Full Text] [Related]
14. [Anesthetic management of patients with interstitial cystitis during intravesical resiniferatoxin therapy].
Komura M; Kuroiwa M; Numazawa K; Yamada T; Hoka S
Masui; 2005 Feb; 54(2):149-52. PubMed ID: 15747509
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions.
Kuo HC
J Urol; 2003 Sep; 170(3):835-9. PubMed ID: 12913711
[TBL] [Abstract][Full Text] [Related]
16. The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input.
Silva C; Ribeiro MJ; Cruz F
J Urol; 2002 Aug; 168(2):575-9. PubMed ID: 12131313
[TBL] [Abstract][Full Text] [Related]
17. Intravesical resiniferatoxin for the treatment of women with idiopathic detrusor overactivity and urgency incontinence: A single dose, 4 weeks, double-blind, randomized, placebo controlled trial.
Rios LA; Panhoca R; Mattos D; Srugi M; Bruschini H
Neurourol Urodyn; 2007; 26(6):773-8. PubMed ID: 17638305
[TBL] [Abstract][Full Text] [Related]
18. Role of C afferent fibers and monitoring of intravesical resiniferatoxin therapy for patients with idiopathic detrusor overactivity.
Yokoyama T; Nozaki K; Fujita O; Nose H; Inoue M; Kumon H
J Urol; 2004 Aug; 172(2):596-600. PubMed ID: 15247740
[TBL] [Abstract][Full Text] [Related]
19. Lower Urinary Tract Symptoms: What's New in Medical Treatment?
Peyronnet B; Brucker BM; Michel MC
Eur Urol Focus; 2018 Jan; 4(1):17-24. PubMed ID: 29665997
[TBL] [Abstract][Full Text] [Related]
20. Comparison of urodynamic results and quality of life between women with interstitial cystitis and overactive bladder.
Hsu CC; Liang CC; Chang SD; Chien CW; Hsieh WC
Taiwan J Obstet Gynecol; 2020 Jan; 59(1):39-42. PubMed ID: 32039798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
